Occult carcinoma in 866 reduction mammaplasties: Preserving the choice of lumpectomy

Plastic and Reconstructive Surgery

Volumn 127, Issue 2, 2011, Pages 525-530

  Slezak, Sheri ^a   Bluebond Langner, Rachel ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BREAST RECONSTRUCTION; BREAST TUMOR; FEMALE; HUMAN; INCIDENTAL FINDING; INTRADUCTAL CARCINOMA; LUNG CARCINOMA; MIDDLE AGED; PAGET NIPPLE DISEASE; RETROSPECTIVE STUDY; SEGMENTAL MASTECTOMY;

ADULT; AGED; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, INTRADUCTAL, NONINFILTRATING; CARCINOMA, LOBULAR; FEMALE; HUMANS; INCIDENTAL FINDINGS; MAMMAPLASTY; MASTECTOMY, SEGMENTAL; MIDDLE AGED; RETROSPECTIVE STUDIES;

EID: 79951630521     PISSN: 00321052     EISSN: None     Source Type: Journal    
DOI: 10.1097/PRS.0b013e3181fed5dc     Document Type: Article

References (31)

1. American Society of Plastic Surgeons. Report of 2008 statistics. Available at: http://www.plasticsurgery.org/media/ stats/2008. Accessed April 18, 2010.
2. American Cancer Society. Leading sites of new cancer cases and deaths 2009. Available at: http://www.cancer.org/acs/groups/ content/@nho/documents/ document/f861009final90809pdf. pdf. Accessed November 19, 2010.
3. Tang CL, Brown MH, Levine R, Sloan M, Chong N, Holowaty E. A follow-up study of 105 women with breast cancer following reduction mammaplasty. Plast Reconstr Surg. 1999;103:1687-1690. (Pubitemid 29206872)
4. Jansen DA, Murphy M, Kind GM, Sands K. Breast cancer in reduction mammoplasty: Case reports and a survey of plastic surgeons. Plast Reconstr Surg. 1998;101:361-364. (Pubitemid 28106337)
5. Dotto J, Kluk M, Geramizadeh B, Tavassoli FA. Frequency of clinically occult intraepithelial and invasive neoplasia in reduction mammoplasty specimens: A study of 516 cases. Int J Surg Pathol. 2008;16:25-30.
6. Colwell AS, Kukreja J, Breuing KH, Lester S, Orgill DP. Occult breast carcinoma in reduction mammaplasty specimens: 14-year experience. Plast Reconstr Surg. 2004;113:1984-1988. (Pubitemid 39201715)
7. Kakagia D, Fragia K, Grekou A, Tsoutsos D. Reduction mammaplasty specimens and occult breast carcinomas. Eur J Surg Oncol. 2005;31:19-21. (Pubitemid 40103920)
8. Clark CJ, Whang S, Paige KT. Incidence of precancerous lesions in breast reduction tissue: A pathologic review of 562 consecutive patients. Plast Reconstr Surg. 2009;124:1033-1039.
9. Viana GA, Pitanguy I, Torres E. Histopathological findings in surgical specimens obtained from reduction mammaplasties. Breast 2005;14:242-248. (Pubitemid 40740438)
10. Ambaye AB, MacLennan SE, Goodwin AJ, Suppan T, Naud S, Weaver DL. Carcinoma and atypical hyperplasia in reduction mammaplasty: Increased sampling leads to increased detection. A prospective study. Plast Reconstr Surg. 2009;124: 1386-1392.
11. Bernard JR Jr, Vallow LA, DePeri ER, et al. In newly diagnosed breast cancer, screening MRI of the contralateral breast detects mammographically occult cancer, even in elderly women: The Mayo Clinic in Florida experience. Breast J. 2010; 16:118-126.
12. Petit JY, Rietjens M, Contesso G, Bertin F, Gilles R. Contralateral mastoplasty for breast reconstruction: A good opportunity for glandular exploration and occult carcinomas diagnosis. Ann Surg Oncol. 1997;4:511-515. (Pubitemid 127725227)
13. Ricci MD, Munhoz AM, Pinotti M, et al. The influence of reduction mammaplasty techniques in synchronous breast cancer diagnosis and metachronous breast cancer prevention. Ann Plast Surg. 2006;57:125-133.
14. Renz DM, Böttcher J, Baltzer PA, et al. The contralateral synchronous breast carcinoma: A comparison of histology, localization, and magnetic resonance imaging characteristics with the primary index cancer. Breast Cancer Res Treat. 2010; 120:449-459.
15. Wright FC, Eskicioglu C, Glazier J, Jong R, Causer P, Quan ML. Women with locally advanced breast cancer are not at higher risk for contralateral synchronous breast cancer. Breast J. 2008;14:556-561.
16. Dillman RO, Chico S, Finestone S. Utilization of breastconserving surgery in breast cancer. J Clin Oncol. 2001;19: 4350-4351. (Pubitemid 33096787)
17. Morrow M, White J, Moughan J, et al. Factors predicting the use of breast-conserving therapy in stage I and II breast carcinoma. J Clin Oncol. 2001;19:2254-2260.
18. Fisher B, Anderson S, Bryant J, et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med. 2002;347:1233-1241. (Pubitemid 35176242)
19. Golshan M, Lesnikoski BA, Lester S. Sentinel lymph node biopsy for occult breast cancer detected during breast reduction surgery. Am Surg. 2006;72:397-400. (Pubitemid 46940735)
20. Rudolph R, Niedbala AR. Surgical management of the patient with invasive carcinoma discovered at reduction mammoplasty. Am Surg. 2003;69:1003-1005.
21. Butler CE, Hunt KK, Singletary SE. Management of breast carcinoma identified intraoperatively during reduction mammaplasty. Ann Plast Surg. 2003;50:193-197. (Pubitemid 36182479)
22. Ioffe O, McDowell P. Personal communication; 2010.
23. Schrenk P, Wölfl S, Bogner S, Huemer GM, Wayand W. Symmetrization reduction mammaplasty combined with sentinel node biopsy in patients operated for contralateral breast cancer. J Surg Oncol. 2006;94:9-15. (Pubitemid 43967716)
24. Pitanguy I, Torres E, Salgado F, Pires Viana GA. Breast pathology and reduction mammaplasty. Plast Reconstr Surg. 2005;115:729-734. (Pubitemid 40316412)
25. The Royal College of Pathologists. Histopathology of limited or no clinical value. Available at: http://www.rcpath.org/ resources/pdf/HOLNCV- 2ndEdition.pdf. Accessed March 24, 2010.
26. Cook S, Fuller CE. Does histopathological examination of breast reduction specimens affect patient management and clinical follow up? J Clin Pathol. 2004;57:286-289. (Pubitemid 38338842)
27. Olack JB, Martin RT, Tirabassi MV, Stueber K. Cost-benefit analysis for pathologic examination of reduction mammoplasty specimens. Paper presented at: Plastic Surgery 2005, American Society of Plastic Surgery Annual Meeting; September 24-28, 2005; Chicago, Ill.
28. American Cancer Society. Breast cancer screening guidelines. Available at: http://www.cancer.org/docroot/NWS/content/NWS-1-1x-Updated-Breast-Cancer- Screening-Guidelines-Released.asp. Accessed March 24, 2010.
29. American Congress of Obstetricians and Gynecologists. Breast cancer screening recommendations. Available at: http://www.acog.org/from-home/Misc/ uspstfInterpretation. cfm. Accessed March 24, 2010.
30. U.S. Preventive Services Task Force. Screening for breast cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2010;152:199-200.
31. Elmore JG, Armstrong K, Lehman CD. Screening for breast cancer. JAMA. 2005;293:1245-1256. (Pubitemid 40327910)